Singapore markets close in 3 hours 57 minutes
AIRLINES

Omicron’s rapid spread shreds budding recovery in air travel

Lonza Group Ltd (LZAGY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
76.17-1.96 (-2.51%)
At close: 03:52PM EST
Full screen
Trade prices are not sourced from all markets
Previous close78.13
Open77.37
Bid0.00 x 0
Ask0.00 x 0
Day's range76.06 - 77.45
52-week range55.69 - 86.31
Volume44,973
Avg. volume40,512
Market cap56.581B
Beta (5Y monthly)0.42
PE ratio (TTM)73.40
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield0.33 (0.42%)
Ex-dividend date10 May 2021
1y target estN/A
  • Motley Fool

    Should You Have Lonza Stock on Your Watchlist?

    In this Motley Fool Live video recorded on Nov. 3, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss whether investors should have Lonza on their watchlists. Keith Speights: Brian, one final topic before we get to questions.

  • Reuters

    Vaccine business helps Lonza lift 2021 sales outlook

    ZURICH (Reuters) -Swiss contract drugmaker Lonza raised its 2021 outlook on Friday after booming business making ingredients for COVID-19 vaccines and strong growth elsewhere helped it beat analysts' expectations during the first half of the year. "In the prior year we provided an estimate for how much we expected from Moderna sales for 2021...the number is much higher given our ability to increase output at our existing facilities," Chief Financial Officer Rodolfo Savitzky told reporters. Its previous guidance had been for sales growth in the low double-digit range.